CA117:666F Wang et al., (Zhongguo Yaolixw Yu DulixueZazhi, 1992, 6(1), 36-40). |
CA72:119700, VonCube et al., /Naunyn-Schmiedebergs Arch. Pharmakol., 265(5) 455-73 1970). |
The Mack Trdux, 11th ed., Merck & Co., Inc., NJ, 1989, pp. 610-611 & 936. |
Huang and Qin, Acta Pharmacologica Sinica 3: 9-13 (1982) Analgesic and Other CNS Depressive Effects of Dihydroetorphine. |
Huang and Qin, Acta Pharmacologica Sinica 3: 81-84 (1982) Physical Dependence of Dihydroetorphine in Mice and Monkeys. |
Cao et al, Chin. J. Clin. Pharmacol. 6: 54-59 (1990) Drug Dependence on Dihydroetorphine. |
Wang, Liu and Qin, Chinese J. Pharmacology and Toxicology 6: 36-40 (1992) Experimental therapeutic effects of dihydroetorphine in morphine-dependent rats and monkeys. |
Huang et al, Acta Pharmacologica Sinica 9: 308-312 (1988) Pharmacodynamics and Pharmacokinetics of Dihydroetorphine Hydrochloride administered Sublingually in Mice and Rats. |
Wu and Sun, Chung Hua Chung Liu Tsa Chih 13: 64-67 (1991) Dihydroetorphine Hydrochloride for Moderate and Severe Cancer Pain. |
Thorn-Gray and Levitt, Behavioral Neuroscience, 97(5) 768-778 (1983) Rat Brain sites responsive to etorphine: Analgesia and catatonia. |
Williams et al, Proc. Soc. Exp. Biol. Med., 131 (1) 97-100 (1969). Analgesic tolerance to etorphine and morphine in the mouse. |
Blane, J. Pharm. Pharmac. 19, 781-782 (1967) Absence of respiratory depression in the newborn rat after maternal administration of etorphine by sublingual route. |
Shen and Crain, Brain Research, 531, 1-7 (1990) Cholera toxin-B subunit blocks excitatory effects of opioids on sensory neuron potentials indicating that GM1 ganglioside may regulate Gs-linked opioid receptor functions. |
Crain and Shen, Trends in Pharmacological Sciences, 11(2), 1-7 (1990) Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons. |
Bentley et al, Nature, 206, 102-103 (1965) Compounds possessing Morphine-antagonizing or Powerful Analgesic Properties. |
Bently and Hardy, Proc. Chem. Soc., p. 220 (1963) New potent analgesics in the morphine series. |
Bently and Hardy, J. Am. Chem. Soc. 89, 3281-3286 (1967) Novel analgesics and molecular rearrangements in the morphine-thebaine group III. Alcohols of the . . . . |
Blane and Robbie, Brit. J. Pharma. Chemother. 20, 252-253 (1970) Trial of etorphine hydrochloride (M99 Reckitt) in carcinoma pain: A preliminary report. |
Blane et al., Brit. J. Pharma. Chemother. 30, 11-22 (1967) Action of etorphine hydrochloride (M99): A Potent Morphine-like agent. |
Jasinski et al, Clin. Pharma. Ther. 17, 267-272 (1975) Etorphine in Man I. Subjective effects and supression of morphine abstinence. |
WHO Expert Committee on Dependence-producing Drugs, Fifteenth Report, p. 5 (1966). |
Attali et al, Brain Research, 517, 182-188 (1990) Characterization of kappa opiate receptors in rat spinal cord-DRG cultures and their regulation by chronic. |
Cho et al, Proc. Nat'l. Acad. Sci. 80, 5176-5180 (1983) Isolation of opiate binding components by affinity chromatography and reconstruction of binding active. |
MacDonald et al, Science, 199, 1449-1451 (1978) Specific opiate induced depression of transmitter release from DRG cells in culture. |
Qin and Huang, International Symposium on New Drug Research and Development Beijing, China, (Oct. 1991), Research Advance and Clinical Application of Highly Potent Dihydroetorphine Hydrochloride. |
Qin, 5th National Congress of Neuropharmacology, Mar. 1992 Progress in Research of Dihydroetorphine: From an Analgesic to Substitution Agent in Treatment of Drug Addiction. |
Kosterlitz and Waterfield, Ann. Rev. Pharmacol. 15, 29-47 (1975) InVitro Models in the Study of Structure-Activity Relationships of Narcotic Analgesics. |
Qin, New Drugs and Clinical Remedies, 1992 Research Advances of Dihydroetorphine: From Analgesia to Detoxification. |
Wang et al, Chin. J. Clin. Pharmacol. 1992; 8(2): 106-112 Clinical Investigation on Detoxification of Heroin Addiction with Dihydroetorphine Hydrochloride. |